Buscar
01/10/2024
Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis
Augustin, M, Gottlieb, AB, Lebwohl, M, Pinter, A, Warren, RB, Puig, L, Warham, R, Lambert, J, Wiegratz, S, Szilagyi, B, Blauvelt, A. Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis. Dermatology and Therapy. 2024; 14(10)DOI:10.1007/s13555-024-01261-6. PMID:39285121. IF:4.200(Q1/1D).
01/10/2024
Treatment of functionally nonsignificant vulnerable plaques in multivessel STEMI: design of the VULNERABLE trial
Gomez-Lara, J, Lopez-Palop, R, Rumiz, E, Jurado-Roman, A, Gomez-Menchero, A, Valencia, J, Fernandez, E, Ramirez, LRG, Brugaletta, S, Millan, R, Cortes, C, Tejedor, P, Gutierrez-Barrios, A, Flores, X, Cid-alvarez, AB, Garcia-Blas, S, Garcia-Camarero, T, Vicente, JAL, Vaquerizo, B, Soriano, JGC, Caballero, J, Piris, RMC, Sanchez-Elvira, G, Oyarzabal, L, Pernigotti, A, Tramullas, A, Antuna, P, Rodriguez-Leor, O, Ojeda, S, Rossello, X, Gomez-Hospital, JA, Bermejo, J, Garcia-Garcia, HM, Prado, APD, Gutierrez-Ibanes, E. Treatment of functionally nonsignificant vulnerable plaques in multivessel STEMI: design of the VULNERABLE trial. REC, interventional cardiology. 2024; 6(4)DOI:10.24875/RECIC.M24000468. PMID:. IF:(Q/D).
01/10/2024
PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia.
Borràs C, Canyelles M, Girona J, Ibarretxe D, Santos D, Revilla G, Llorente-Cortes V, Rotllan N, Kovanen PT, Jauhiainen M, Lee-Rueckert M, Masana L, Arrieta F, Martínez-Botas J, Gómez-Coronado D, Ribalta J, Tondo M, Blanco-Vaca F, Escolà-Gil JC. PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia.. Jacc-Basic To Translational Science. 2024; 9(10)DOI:10.1016/j.jacbts.2024.06.008. PMID:39534644. IF:(Q/D).
01/10/2024
Effect of Moderate Beer Intake on the Lipid Composition of Human Red Blood Cell Membranes
López-Yerena, A, Muñoz-García, N, Villaplana, VD, Padro, T, Badimon, L. Effect of Moderate Beer Intake on the Lipid Composition of Human Red Blood Cell Membranes. Nutrients. 2024; 16(20)DOI:10.3390/nu16203541. PMID:39458535. IF:5.000(Q1/2D).
30/09/2024
Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain
Puig, T, Leache, L, González-Senac, NM, Carreras, E, Gutiérrez-Valencia, M, Losa, L, Revuelta-Herrero, JL, Marrero-Alvarez, P, de Miguel, M, Arredondo, AA, Aranguren, A, Vilariño, A, Ruiz, VE, Fernández, I, Bilbao, J, González-Guerrero, C, del Pino, B, Garin, N. Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain. BMC Geriatrics. 2024; 24(1)DOI:10.1186/s12877-024-05308-3. PMID:39350081. IF:3.800(Q2/4D).
30/09/2024
Consensus statement addressing controversies and guidelines on pediatric urolithiasis (vol 42, 473, 2024)
Güven, S, Tokas, T, Tozsin, A, Haid, B, Lendvay, TS, Silay, S, Mohan, VC, Cansino, JR, Saulat, S, Straub, M, Tur, AB, Akguel, B, Samotyjek, J, Lusuardi, L, Ferretti, S, Cavdar, OF, Ortner, G, Sultan, S, Choong, S, Micali, S, Saltirov, I, Sezer, A, Netsch, C, de Lorenzis, E, Cakir, OO, Zeng, G, Gozen, AS, Bianchi, G, Jurkiewicz, B, Knoll, T, Rassweiler, J, Ahmed, K, Sarica, K. Consensus statement addressing controversies and guidelines on pediatric urolithiasis (vol 42, 473, 2024). WORLD JOURNAL OF UROLOGY. 2024; 42(1)DOI:10.1007/s00345-024-05282-w. PMID:39348069. IF:2.900(Q2/3D).
28/09/2024
Assessing and correcting neighborhood socioeconomic spatial sampling biases in citizen science mosquito data collection
Padilla-Pozo, A, Bartumeus, F, Montalvo, T, Sanpera-Calbet, I, Valsecchi, A, Palmer, JRB. Assessing and correcting neighborhood socioeconomic spatial sampling biases in citizen science mosquito data collection. Scientific Reports. 2024; 14(1)DOI:10.1038/s41598-024-73416-6. PMID:39341898. IF:3.900(Q1/2D).
27/09/2024
Young age and adequate BCG are key factors for optimal BCG treatment efficacy in non-muscle-invasive bladder cancer
Liu, K, Nicoletti, R, Zhao, HD, Chen, X, Wu, HW, Leung, CH, D'Andrea, D, Laukhtina, E, Soria, F, Gallioli, A, Wroclawski, ML, Castellani, D, Gauhar, V, Rivas, JG, Enikeev, D, Gontero, P, Shariat, SF, Chiu, PKF, Ng, CF, Teoh, JYC. Young age and adequate BCG are key factors for optimal BCG treatment efficacy in non-muscle-invasive bladder cancer. WORLD JOURNAL OF UROLOGY. 2024; 42(1)DOI:10.1007/s00345-024-05218-4. PMID:39331198. IF:2.900(Q2/3D).